Neuroendocrine Tumor Treatment Market Size, Share & Trends Report

Neuroendocrine Tumor Treatment Market Size, Share & Trends Analysis Report By Type (Meningiomas, Adrenal Cancer, Carcinoid Tumors, Paraganglioma), By Product, By Site, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-2-68038-624-0
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Market Segmentation

  • Neuroendocrine Tumor Treatment Type Outlook (Revenue, USD Billion, 2018 - 2030)
    • Meningiomas
    • Adrenal Cancer
    • Carcinoid Tumors
    • Paraganglioma
    • Pheochromocytoma
    • Others
  • Neuroendocrine Tumor Treatment Product Outlook (Revenue, USD Billion, 2018 - 2030)
    • Somatostatin Analogs (SSAs)
    • Targeted Therapy
    • Others
  • Neuroendocrine Tumor Treatment Site Outlook (Revenue, USD Billion, 2018 - 2030)
    • Lung
    • Pancreas
    • Colon
    • Small Intestine
    • Rectum
    • Stomach
    • Others
  • Neuroendocrine Tumor Treatment End Use Outlook (Revenue, USD Billion, 2018 - 2030)
    • Hospitals
    • Clinics
    • Others
  • Neuroendocrine Tumor Treatment Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • North America Neuroendocrine Tumor Treatment Market, by Type
        • Meningiomas
        • Adrenal Cancer
        • Carcinoid Tumors
        • Paraganglioma
        • Pheochromocytoma
        • Others
      • North America Neuroendocrine Tumor Treatment Market, by Product
        • Somatostatin Analogs (SSAs)
        • Targeted Therapy
        • Others
      • North America Neuroendocrine Tumor Treatment Market, by Site
        • Lung
        • Pancreas
        • Colon
        • Small Intestine
        • Rectum
        • Stomach
        • Others
      • North America Neuroendocrine Tumor Treatment Market, by End Use
        • Hospitals
        • Clinics
        • Others
      • U.S.
        • U.S. Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • U.S. Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • U.S. Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • U.S. Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Canada
        • Canada Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Canada Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Canada Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Canada Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Mexico
        • Mexico Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Mexico Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Mexico Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Mexico Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
    • Europe
      • Europe Neuroendocrine Tumor Treatment Market, by Type
        • Meningiomas
        • Adrenal Cancer
        • Carcinoid Tumors
        • Paraganglioma
        • Pheochromocytoma
        • Others
      • Europe Neuroendocrine Tumor Treatment Market, by Product
        • Somatostatin Analogs (SSAs)
        • Targeted Therapy
        • Others
      • Europe Neuroendocrine Tumor Treatment Market, by Site
        • Lung
        • Pancreas
        • Colon
        • Small Intestine
        • Rectum
        • Stomach
        • Others
      • Europe Neuroendocrine Tumor Treatment Market, by End Use
        • Hospitals
        • Specialty Clinics
        • Others
      • UK
        • UK Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • UK Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • UK Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • UK Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Germany
        • Germany Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Germany Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Germany Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Germany Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • France
        • France Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • France Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • France Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • France Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Italy
        • Italy Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Italy Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Italy Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Italy Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Spain
        • Spain Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Spain Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Spain Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Spain Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Norway
        • Norway Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Norway Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Norway Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Norway Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Denmark
        • Denmark Neuroendocrine Tumor Treatment Market, by Type
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Denmark Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Denmark Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Denmark Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Sweden
        • Sweden Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Sweden Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Sweden Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Sweden Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
    • Asia Pacific
      • Asia Pacific Neuroendocrine Tumor Treatment Market, by Type
        • Meningiomas
        • Adrenal Cancer
        • Carcinoid Tumors
        • Paraganglioma
        • Pheochromocytoma
        • Others
      • Asia Pacific Neuroendocrine Tumor Treatment Market, by Product
        • Somatostatin Analogs (SSAs)
        • Targeted Therapy
        • Others
      • Asia Pacific Neuroendocrine Tumor Treatment Market, by Site
        • Lung
        • Pancreas
        • Colon
        • Small Intestine
        • Rectum
        • Stomach
        • Others
      • Asia Pacific Neuroendocrine Tumor Treatment Market, by End Use
        • Hospitals
        • Specialty Clinics
        • Others
      • Japan
        • Japan Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Japan Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Japan Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Japan Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • China
        • China Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • China Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • China Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • China Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • India
        • India Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • India Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • India Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • India Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • South Korea
        • South Korea Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • South Korea Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • South Korea Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • South Korea Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Australia
        • Australia Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Australia Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Australia Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Australia Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Singapore
        • Singapore Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Singapore Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Singapore Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Singapore Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
    • Latin America
      • Latin America Neuroendocrine Tumor Treatment Market, by Type
        • Meningiomas
        • Adrenal Cancer
        • Carcinoid Tumors
        • Paraganglioma
        • Pheochromocytoma
        • Others
      • Latin America Neuroendocrine Tumor Treatment Market, by Product
        • Somatostatin Analogs (SSAs)
        • Targeted Therapy
        • Others
      • Latin America Neuroendocrine Tumor Treatment Market, by Site
        • Lung
        • Pancreas
        • Colon
        • Small Intestine
        • Rectum
        • Stomach
        • Others
      • Latin America Neuroendocrine Tumor Treatment Market, by End Use
        • Hospitals
        • Specialty Clinics
        • Others
      • Brazil
        • Brazil Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Brazil Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Brazil Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Brazil Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Argentina
        • Argentina Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Argentina Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Argentina Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Argentina Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
    • MEA
      • MEA Neuroendocrine Tumor Treatment Market, by Type
        • Meningiomas
        • Adrenal Cancer
        • Carcinoid Tumors
        • Paraganglioma
        • Pheochromocytoma
        • Others
      • MEA Neuroendocrine Tumor Treatment Market, by Product
        • Somatostatin Analogs (SSAs)
        • Targeted Therapy
        • Others
      • MEA Neuroendocrine Tumor Treatment Market, by Site
        • Lung
        • Pancreas
        • Colon
        • Small Intestine
        • Rectum
        • Stomach
        • Others
      • MEA Neuroendocrine Tumor Treatment Market, by End Use
        • Hospitals
        • Specialty Clinics
        • Others
      • South Africa
        • South Africa Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • South Africa Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • South Africa Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • South Africa Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Saudi Arabia
        • Saudi Arabia Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Saudi Arabia Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Saudi Arabia Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Saudi Arabia Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • UAE
        • UAE Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • UAE Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • UAE Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • UAE Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others
      • Kuwait
        • Kuwait Neuroendocrine Tumor Treatment Market, by Type
          • Meningiomas
          • Adrenal Cancer
          • Carcinoid Tumors
          • Paraganglioma
          • Pheochromocytoma
          • Others
        • Kuwait Neuroendocrine Tumor Treatment Market, by Product
          • Somatostatin Analogs (SSAs)
          • Targeted Therapy
          • Others
        • Kuwait Neuroendocrine Tumor Treatment Market, by Site
          • Lung
          • Pancreas
          • Colon
          • Small Intestine
          • Rectum
          • Stomach
          • Others
        • Kuwait Neuroendocrine Tumor Treatment Market, by End Use
          • Hospitals
          • Specialty Clinics
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon